Table V.
Results of the TFAS (tractwise fractional anisotropy statistics) analysis
| FA patients | FA controls | No. voxels | t‐test | |
|---|---|---|---|---|
| PLS | ||||
| CC | 0.29 ± 0.10 | 0.36 ± 0.11 | 10,841 | <0.001 |
| CST | 0.38 ± 0.11 | 0.41 ± 0.12 | 3,841 | <0.001 |
| HSP | ||||
| CC | 0.31 ± 0.08 | 0.37 ± 0.11 | 18,451 | <0.001 |
| CST | 0.41 ± 0.12 | 0.43 ± 0.11 | 3,958 | <0.001 |
| X‐SBMA | ||||
| CC | 0.35 ± 0.12 | 0.35 ± 0.12 | 21,497 | 0.34 |
| CST | 0.42 ± 0.12 | 0.44 ± 0.13 | 4,257 | <0.001 |
Tractwise fractional anisotropy (TFAS) results for the PLS‐group, the HSP‐group, and for the X‐SBMA‐group. Data are presented as mean values ± SD. A t‐test was performed for the comparison between mean FA values of patients and controls.